The current management of carotid atherosclerotic disease: Who, when and how?

Interactive Cardiovascular and Thoracic Surgery

Volumn 16, Issue 3, 2013, Pages 339-346

  Ritter, Jens C ^a   Tyrrell, Mark R ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Cardiovascular disease; Carotid artery disease; Carotid endarterectomy; Stroke

Indexed keywords

ACETYLSALICYLIC ACID; ATORVASTATIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIPYRIDAMOLE; FIBRIC ACID DERIVATIVE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ROSUVASTATIN; SIMVASTATIN; THIAZIDE DIURETIC AGENT;

ANESTHESIA; ARTERY GRAFT; ARTICLE; BALLOON; BARE METAL STENT; BLEEDING; BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CAROTID ARTERIOGRAPHY; CAROTID ARTERY DISEASE; CAROTID ARTERY OBSTRUCTION; CAROTID ARTERY STENTING; CAROTID ATHEROSCLEROSIS; CAROTID ENDARTERECTOMY; CAROTID STUMP SYNDROME; CEREBRAL GLOBAL MALPERFUSION; CEREBROVASCULAR ACCIDENT; CEREBROVASCULAR DISEASE; CORONARY ARTERY DISEASE; DIABETES CONTROL; EMBOLIC PROTECTION DEVICE; FOUR VESSEL DISEASE; HEART SURGERY; HUMAN; HYPERTENSION; LIFESTYLE MODIFICATION; LOW DRUG DOSE; META ANALYSIS (TOPIC); PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SEX DIFFERENCE; SHUNTING; SURGICAL TECHNIQUE; SYMPTOMATOLOGY; TRANSIENT ISCHEMIC ATTACK; TRANSITIONAL BLINDNESS;

AMAUROSIS FUGAX; ANGIOPLASTY; ASYMPTOMATIC DISEASES; CARDIOVASCULAR AGENTS; CAROTID STENOSIS; ENDARTERECTOMY, CAROTID; HEMODYNAMICS; HUMANS; ISCHEMIC ATTACK, TRANSIENT; PATIENT SELECTION; PREDICTIVE VALUE OF TESTS; RISK ASSESSMENT; RISK FACTORS; RISK REDUCTION BEHAVIOR; SEVERITY OF ILLNESS INDEX; STENTS; STROKE; TREATMENT OUTCOME;

EID: 84874287819     PISSN: 15699293     EISSN: 15699285     Source Type: Journal    
DOI: 10.1093/icvts/ivs453     Document Type: Article

References (72)

1. Mohr JP, Caplan LR, Melski JW, Goldstein RJ, Duncan GW, Kistler JP et al. The Harvard Cooperative Stroke Registry: a prospective registry. Neurology 1978;28:754-62.
2. Truelsen T, Ekman M, Boysen G. Cost of stroke in Europe. Eur J Neurol 2005;12(Suppl 1):78-84.
3. Petty GW, Brown RD Jr, Whisnant JP, Sicks JD, O'Fallon WM, Wiebers DO. Ischemic stroke subtypes: a population based study of incidence and risk factors. Stroke 1999;30:2513-6.
4. White H, Boden-Albala B, Wang C, Elkind MS, Rundek T, Wright CB et al. Ischemic stroke subtype incidence among whites, blacks and Hispanics: the Northern Manhattan Study. Circulation 2005;111:1327-31.
5. Goldstein LB, Bushnell CD, Adams RJ, Appel LJ, Braun LT, Chaturvedi S et al. Guidelines for the primary prevention of stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2011;42:517-84.
6. Miller NR, Newman NJ (eds). Walsh and Hoyt's Clinical Neuroophthalmology. 5th edn. Baltimore: Lippencott, Williams & Wilkins 1998.
7. Benavente O, Eliasziw M, Streifler JY, Fox AJ, Barnett HJ, Meldrum H; North American Symptomatic Carotid Endarterectomy Trial Collaborators. Prognosis after transient monocular blindness associated with carotidartery stenosis. N Engl J Med 2001;345:1084-90.
8. Anderson DC, Kappelle LJ, Eliasziw M, Babikian VL, Pearce LA, Barnett HJ. Occurrence of hemispheric and retinal ischemia in atrial fibrillation compared with carotid stenosis. Stroke 2002;33:1963-7.
9. Ferguson GG, Eliasziw M, Barr HW, Clagett GP, Barnes RW, Wallace MC et al. The North American Symptomatic Carotid Endarterectomy Trial: surgical results in 1415 patients. Stroke 1999;30:1751-8.
10. Randomised trial of endarterectomy for recently symptomatic carotid stenosis: final results of the MRC European Carotid Surgery Trial (ECST). Lancet 1998;351:1379-87.
11. Eliasziw M, Rankin RN, Fox AJ, Haynes RB, Barnett HJ. Accuracy and prognostic consequences of ultrasonography in identifying severe carotid artery stenosis. North American Symptomatic Carotid Endarterectomy Trial (NASCET) Group. Stroke 1995;26:1747-52.
12. Oates C, Naylor AR, Hartshorne T, Charles SM, Fail T, Humphries K et al. Reporting carotid ultrasound investigations in the United Kingdom. Eur J Vasc Endovasc Surg 2009;37:251-61.
13. Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002;324:71-86.
14. Chen ZM, Sandercock P, Pan HC, Counsell C, Collins R, Liu LS et al. Indications for early aspirin use in acute ischemic stroke: a combined analysis of 40,000 randomized patients from the Chinese Acute Stroke Trial and the International Stroke Trial. Stroke 2000;31:1240-49.
15. De Schryver EL, Algra A, van Gijn J. Dipyridamole for preventing stroke and other vascular events in patients with vascular disease. Cochrane Database Syst Rev 2007;(3):CD001820.
16. CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 1996;348:1329-39.
17. Diener HC, Bogousslavsky J, Brass LM, Cimminiello C, Csiba L, Kaste M; MATCH investigators. Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebocontrolled trial. Lancet 2004;364:331-7.
18. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 2002;360:7-22.
19. O'Regan C, Wu P, Arora P, Perri D, Mills EJ. Statin therapy in stroke prevention: a meta-analysis involving 121,000 patients. Am J Med 2008;121: 24-33.
20. Brugts JJ, Yetgin T, Hoeks SE, Gotto AM, Shepherd J, Westendorp RG et al. The benefits of statins in people without established cardiovascular disease but with cardiovascular risk factors: meta-analysis of randomised controlled trials. BMJ 2009;338:b2376.
21. Amarenco P, Goldstein LB, Szarek M, Sillesen H, Rudolph AE, Callahan A 3rd et al.; SPARCL Investigators. Effects of intense low-density lipoprotein cholesterol reduction in patients with stroke or transient ischemic attack: the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. Stroke 2007;38:3198-204.
22. Ridker PM, Danielson E, Fonseca FA, Genest J, Gotto AM Jr, Kastelein JJ et al.; JUPITER Study Group. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med 2008; 359:2195-207.
23. Weng TC, Yang YH, Lin SJ, Tai SH. A systematic review and meta-analysis on the therapeutic equivalence of statins. J Clin Pharm Ther 2010;35: 139-51.
24. Jun M, Foote C, Lv J, Neal B, Patel A, Nicholls SJ et al. Effects of fibrates on cardiovascular outcomes: a systematic review and meta-analysis. Lancet 2010;375:1875-84.
25. Meta-analysis of hypertension treatment trials. Lancet 1990;335:1092-4.
26. Dahlof B, Sever PS, Poulter NR, Wedel H, Beevers DG, Caulfield M et al. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial. Lancet 2005;366:895-906.
27. Dahlof B, Devereux RB, Kjeldsen SE, Julius S, Beevers G, de Faire U et al. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet 2002;359:995-1003.
28. Heart Outcomes Prevention Evaluation Study Investigators. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Lancet 2000;355:253-9.
29. Khan N, McAlister FA. Re-examining the efficacy of beta-blockers for the treatment of hypertension: a meta-analysis. CMAJ 2006;174:1737-42.
30. Kernan WN, Inzucchi SE. Type 2 diabetes mellitus and insulin resistance: stroke prevention and management. Curr Treat Options Neurol 2004;6: 443-50.
31. Howard G, Wagenknecht LE, Cai J, Cooper L, Kraut MA, Toole JF. Cigarette smoking and other risk factors for silent cerebral infarction in the general population. Stroke 1998;29:913-7.
32. Lee AH, Liang W. Life-long physical activity involvement and the risk of ischemic stroke in southern china. Stroke Res Treat 2011;2010:415-41.
33. Winter Y, Rohrmann S, Linseisen J, Lanczik O, Ringleb PA, Hebebrand J et al. Contribution of obesity and abdominal fat mass to risk of stroke and transient ischemic attacks. Stroke 2008;39:3145-51.
34. Liapis CD, Bell PR, Mikhailidis D, Sivenius J, Nicolaides A, Fernandes e Fernandes J et al.; ESVS Guidelines Collaborators. ESVS guidelines. Invasive treatment for carotid stenosis: indications, techniques. Eur J Vasc Endovasc Surg 2009;37(Suppl 4):1-19.
35. www.nice.org.uk
36. Hobson RW 2nd, Mackey WC, Ascher E, Murad MH, Calligaro KD, Comerota AJ et al.; Society for Vascular Surgery. Management of athero-sclerotic carotid artery disease: clinical practice guidelines of the Society for Vascular Surgery. J Vasc Surg 2008;48:480-6.
37. Naylor RA. Known knowns, known unknowns and unknown unknowns: a 2010 update on carotid artery disease. Surgeon 2010;8:79-86.
38. Halliday A, Mansfield A, Marro J, Peto C, Peto R, Potter J et al.; MRC Asymptomatic Carotid Surgery Trial (ACST) Collaborative Group. Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms: randomised controlled trial. Lancet 2004;363:1491-502.
39. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. Endarterectomy for asymptomatic carotid artery stenosis. JAMA 1995;273:1421-8.
40. Naylor AR. Time is brain! Surgeon 2007;5:23-30.
41. Rothwell PM, Eliasziw M, Gutnikov S, Warlow CP, Barnett HJ. Sex difference in the effect of time from symptoms to surgery on benefit from carotid endarterectomy for transient ischemic attack and nondisabling stroke. Stroke 2004;35:2855-61.
42. Endovascular versus surgical treatment in patients with carotid stenosis in the Carotid and Vertebral Artery Transluminal Angioplasty Study (CAVATAS): a randomised trial. Lancet 2001;357:1729-37.
43. Eckstein HH, Ringleb P, Allenberg JR, Berger J, Fraedrich G, Hacke W et al. Results of the Stent-Protected Angioplasty versus Carotid Endarterectomy (SPACE) study to treat symptomatic stenoses at 2 years: a multinational, prospective, randomised trial. Lancet Neurol 2008;7: 893-902.
44. Mas JL, Chatellier G, Beyssen B, Branchereau A, Moulin T, Becquemin JP et al.; EVA-3S Investigators. Endarterectomy versus stenting in patients with symptomatic severe carotid stenosis. N Engl J Med 2006;355:1660-71.
45. Gurm HS, Yadav JS, Fayad P, Katzen BT, Mishkel GJ, Bajwa TK et al.; SAPPHIRE Investigators. Long-term results of carotid stenting versus endarterectomy in high-risk patients. N Engl J Med 2008;358:1572-9.
46. Bonati LH, Dobson J, Algra A, Branchereau A, Chatellier G, Fraedrich G et al.; Carotid Stenting Trialists' Collaboration. Short-term outcome after stenting versus endarterectomy for symptomatic carotid stenosis: a preplanned meta-analysis of individual patient data. Lancet 2010;376:1062-73.
47. Brott TG, Hobson RW II, Howard G, Roubin GS, Clark WM, Brooks W et al. for the CREST Investigators. Stenting versus endarterectomy for treatment of carotid-artery stenosis. N Engl J Med. 2010;363:11-23.
48. Davies SM, Donnan GA. Carotid-artery stenting in stroke prevention. N Eng J Med 2010;363:11-23.
49. Brott TG, Halperin JL, Abbara S, Bacharach JM, Barr JD, Bush RL et al. 2011 ASA/ACCF/AHA/AANN/AANS/ACR/ASNR/CNS/SAIP/SCAI/SIR/SNIS/SVM/SVS Guideline on the management of patients with extracranial carotid and vertebral artery disease. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American Stroke Association, American Association of Neuroscience Nurses, American Association of Neurological Surgeons, American College of Radiology, American Society of Neuroradiology, Congress of Neurological Surgeons, Society of Atherosclerosis Imaging and Prevention, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of NeuroInterventional Surgery, Society for Vascular Medicine, and Society for Vascular Surgery Developed in Collaboration With the American Academy of Neurology and Society of Cardiovascular Computed Tomography. J Am Coll Cardiol 2011;57:e16-94.
50. Ricotta JJ, Aburahma A, Ascher E, Eskandari M, Faries P, Lal BK. Updated society for vascular surgery guidelines for management of extracranial carotid disease. J Vasc Surg 2011;54:e1-31.
51. Kakisis JD, Avgerinos ED, Antonopoulos CN, Giannakopoulos TG, Moulakakis K, Liapis CD. The European Society for Vascular Surgery Guidelines for carotid intervention: an updated independent assessment and literature review. Eur J Vasc Endovasc Surg 2012;44:238-43.
52. Lewis SC, Warlow CP, Bodenham AR, Colam B, Rothwell PM, Torgerson D et al.; GALA Trial Collaborative Group. General anaesthesia versus local anaesthesia for carotid surgery (GALA): a multicentre, randomised controlled trial. Lancet 2008;372:2132-42.
53. Rerkasem K, Rothwell PM. Patch angioplasty versus primary closure for carotid endarterectomy. Cochrane Database Syst Rev 2009;(4):CD000160.
54. Cao PG, de Rango P, Zannetti S, Giordano G, Ricci S, Celani MG. Eversion versus conventional carotid endarterectomy for preventing stroke. Cochrane Database Syst Rev 2001;(1):CD001921.
55. Bond R, Warlow CP, Naylor AR, Rothwell PM; European Carotid Surgery Trialists' Collaborative Group. Variation in surgical and anaesthetic technique and associations with operative risk in the European carotid surgery trial: implications for trials of ancillary techniques. Eur J Vasc Endovasc Surg 2002;23:117-26.
56. Holt PJ, Poloniecki JD, Loftus IM, Thompson MM. The relationship between hospital case volume and outcome from carotid endartectomy in England from 2000 to 2005. Eur J Vasc Endovasc Surg 2007;34: 646-54.
57. Wholey MH, Al-Mubarek N, Wholey MH. Updated review of the global carotid artery stent registry. Catheter Cardiovasc Interv 2003;60: 259-66.
58. Naylor AR. Does the risk of post-CABG stroke merit staged or synchronous reconstruction in patients with symptomatic or asymptomatic carotid disease? J Cardiovasc Surg (Torino) 2009;50:71-81.
59. Dick AM, Brothers T, Robison JG, Elliott BM, Kratz JM, Toole JM et al. Combined carotid endarterectomy and coronary artery bypass grafting versus coronary artery bypass grafting alone: a retrospective review of outcomes at our institution. Vasc Endovascular Surg 2011;45:130-4.
60. Illuminati G, Ricco JB, Caliò F, Pacilè MA, Miraldi F, Frati G et al. Short-term results of a randomized trial examining timing of carotid endarterectomy in patients with severe asymptomatic unilateral carotid stenosis undergoing coronary artery bypass grafting. J Vasc Surg 2011;54: 993-9.
61. Knipp SC, Scherag A, Beyersdorf F, Cremer J, Diener HC, Haverich JA et al.; CABACS Study Group. Randomized comparison of synchronous CABG and carotid endarterectomy vs. isolated CABG in patients with asymptomatic carotid stenosis: the CABACS trial. Int J Stroke 2011 [Epub ahead of print]. doi: 10.1111/j.1747-4949.2011.00687.x.
62. Venkatachalam S, Gray BH, Mukherjee D, Shishehbor MH. Contemporary management of concomitant carotid and coronary artery disease. Heart 2011;97:175-80.
63. Kumar SM, Wang JC, Barry MC, Farrell L, Kelly CJ, Fitzgerald PH et al. Carotid stump syndrome: outcome from surgical management. Eur J Vasc Endovasc Surg 2001;21:214-9.
64. Wang Z, Shen L, Yu J, Gu Y, Wang S, Guan H et al. Management of cerebral ischemia due to Takayasu's arteritis. Chin Med J (Engl) 2002;115: 342-6.
65. Smout J, Macdonald S, Weir G, Stansby G. Carotid artery stenting: relationship between experience and complication rate. Int J Stroke 2010;5: 477-82.
66. Nallamothu BK, Gurm HS, Ting HH, Goodney PP, Rogers MA, Curtis JP et al. Operator experience and carotid stenting outcomes in Medicare beneficiaries. JAMA 2011;306:1338-43.
67. Vogel TR, Dombrovskiy VY, Graham AM. Carotid artery stenting in the nation: the influence of hospital and physician volume on outcomes. Vasc Endovascular Surg 2010;44:89-94.
68. Rothwell PM, Warlow CP. Low risk of ischemic stroke in patients with reduced internal carotid artery lumen diameter distal to severe symptomatic carotid stenosis: cerebral protection due to low poststenotic flow? On behalf of the European Carotid Surgery Trialists' Collaborative Group. Stroke 2000;31:622-30.
69. Schillinger M, Gschwendtner M, Reimers B, Trenkler J, Stockx L, Mair J et al. Does carotid stent cell design matter? Stroke 2008;39:905-9.
70. McKevitt FM, Randall MS, Cleveland TJ, Gaines PA, Tan KT, Venables GS. The benefits of combined anti-platelet treatment in carotid artery stenting. Eur J Vasc Endovasc Surg 2005;29:522-27.
71. Markus HS, Droste DW, Kaps M, Larrue V, Lees KR, Siebler M et al. Dual antiplatelet therapy with clopidogrel and aspirin in symptomatic carotid stenosis evaluated using Doppler embolic signal detection: the Clopidogrel and Aspirin for Reduction of Emboli in Symptomatic Carotid Stenosis (CARESS) trial. Circulation 2005;111:2233-40.
72. Chaturvedi S, Yadav JS. The role of antiplatelet therapy in carotid stenting for ischemic stroke prevention. Stroke 2006;37:1572-77.